These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8709244

  • 21. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.
    Kaplan AH, Swanstrom R.
    Proc Natl Acad Sci U S A; 1991 May 15; 88(10):4528-32. PubMed ID: 2034693
    [Abstract] [Full Text] [Related]

  • 22. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.
    Dannull J, Surovoy A, Jung G, Moelling K.
    EMBO J; 1994 Apr 01; 13(7):1525-33. PubMed ID: 8156990
    [Abstract] [Full Text] [Related]

  • 23. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent.
    Sheng N, Erickson-Viitanen S.
    J Virol; 1994 Oct 01; 68(10):6207-14. PubMed ID: 8083960
    [Abstract] [Full Text] [Related]

  • 24. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
    Bryant ML, Ratner L, Duronio RJ, Kishore NS, Devadas B, Adams SP, Gordon JI.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2055-9. PubMed ID: 2006142
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Specific disulfide formation in the oxidation of HIV-1 zinc finger protein nucleocapsid p7.
    Yu X, Hathout Y, Fenselau C, Sowder RC, Henderson LE, Rice WG, Mendeleyev J, Kun E.
    Chem Res Toxicol; 1995 Jun 15; 8(4):586-90. PubMed ID: 7548739
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.
    Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, Princiotta MF, Bennink JR, Krausslich HG, Yewdell JW.
    Proc Natl Acad Sci U S A; 2000 Nov 21; 97(24):13057-62. PubMed ID: 11087859
    [Abstract] [Full Text] [Related]

  • 30. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990 Nov 21; 8(3):162-3. PubMed ID: 2125537
    [No Abstract] [Full Text] [Related]

  • 31. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
    Pettit SC, Moody MD, Wehbie RS, Kaplan AH, Nantermet PV, Klein CA, Swanstrom R.
    J Virol; 1994 Dec 21; 68(12):8017-27. PubMed ID: 7966591
    [Abstract] [Full Text] [Related]

  • 32. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner.
    Lee YM, Tian CJ, Yu XF.
    J Virol; 1998 Nov 21; 72(11):9061-8. PubMed ID: 9765451
    [Abstract] [Full Text] [Related]

  • 33. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
    Park J, Morrow CD.
    J Virol; 1992 Nov 21; 66(11):6304-13. PubMed ID: 1383561
    [Abstract] [Full Text] [Related]

  • 34. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X, Liu H, Xiao H, Kappes JC.
    Virology; 1996 May 01; 219(1):307-13. PubMed ID: 8623547
    [Abstract] [Full Text] [Related]

  • 35. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo.
    Yu Q, Darlix JL.
    J Virol; 1996 Sep 01; 70(9):5791-8. PubMed ID: 8709195
    [Abstract] [Full Text] [Related]

  • 36. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.
    Zhang Y, Barklis E.
    J Virol; 1995 Sep 01; 69(9):5716-22. PubMed ID: 7637017
    [Abstract] [Full Text] [Related]

  • 37. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM.
    Virology; 2002 Jan 05; 292(1):137-49. PubMed ID: 11878916
    [Abstract] [Full Text] [Related]

  • 38. Inactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters. Characterization of reaction products and proposed mechanism of action.
    Basrur V, Song Y, Mazur SJ, Higashimoto Y, Turpin JA, Rice WG, Inman JK, Appella E.
    J Biol Chem; 2000 May 19; 275(20):14890-7. PubMed ID: 10809733
    [Abstract] [Full Text] [Related]

  • 39. Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.
    Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S.
    J Biochem; 2004 Mar 19; 135(3):447-53. PubMed ID: 15113844
    [Abstract] [Full Text] [Related]

  • 40. The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins.
    Wondrak EM, Louis JM, de Rocquigny H, Chermann JC, Roques BP.
    FEBS Lett; 1993 Oct 25; 333(1-2):21-4. PubMed ID: 8224164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.